The Biotechnology and Pharmaceuticals company caused great surprise for the stock market, posting a relevant growth in fiscal time-frame closing December 31 2023 with operating deficit of $-26.158 million https://csimarket.com/stocks/news.php?code=ADVM&date=2024-03-19100645&utm_source=dlvr.it&utm_medium=tumblr

















